John J. Rhoden
- Radiology, Nuclear Medicine and Imaging top 10%
- Molecular Biology
- Oncology
- Biomedical Engineering
- Immunology
- Co-authors
- K. Dane WittrupMichael M. SchmidtGreg M. ThurberVictor J. WroblewskiChun‐Chao WangJason M. HaughAdam T. MelvinMarkus Weiger
- Topics
- Monoclonal and Polyclonal Antibodies Research (5 papers)Nanoparticle-Based Drug Delivery (3 papers)Radiopharmaceutical Chemistry and Applications (3 papers)
- Journals
- Journal of Biological ChemistryJournal of Cell ScienceMethods in enzymology on CD-ROM/Methods in enzymology
- Partner nations
- United StatesCanada
In The Last Decade
John J. Rhoden
8 papers receiving 318 citations
Peers
Comparison fields: 5 of 53
- Radiology, Nuclear Medicine and Imaging 171
- Molecular Biology 142
- Oncology 106
- Biomedical Engineering 61
- Immunology 47
Countries citing papers authored by John J. Rhoden
This map shows the geographic impact of John J. Rhoden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John J. Rhoden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John J. Rhoden more than expected).
Fields of papers citing papers by John J. Rhoden
This network shows the impact of papers produced by John J. Rhoden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John J. Rhoden. The network helps show where John J. Rhoden may publish in the future.
Co-authorship network of co-authors of John J. Rhoden
This figure shows the co-authorship network connecting the top 25 collaborators of John J. Rhoden. A scholar is included among the top collaborators of John J. Rhoden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John J. Rhoden. John J. Rhoden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Preliminary Dosimetry Results from a First-in-Human Phase I Study Evaluating the Efficacy and Safety of [225Ac]-FPI-1434 in Patients with IGF-1R Expressing Solid Tumors | 5 |
| 2 | 1 | |
| 3 | 50 | |
| 4 | 37 | |
| 5 | Effect of Small-Molecule-Binding Affinity on Tumor Uptake In Vivo: A Systematic Study Using a Pretargeted Bispecific Antibody | 1 |
| 6 | 130 | |
| 7 | 32 | |
| 8 | 66 |
About John J. Rhoden
John J. Rhoden is a scholar working on Biological Psychiatry, Radiology, Nuclear Medicine and Imaging and Biomaterials, having authored 8 papers that have together received 322 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (5 papers), Nanoparticle-Based Drug Delivery (3 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (171 citations), Oncology (106 citations) and Immunology and Allergy (23 citations). John J. Rhoden has collaborated with scholars based in United States and Canada. Frequent co-authors include K. Dane Wittrup, Michael M. Schmidt, Greg M. Thurber, Victor J. Wroblewski, Chun‐Chao Wang, Jason M. Haugh, Adam T. Melvin, Markus Weiger, Matej Krajcovic and John V. Frangioni. Their work appears in journals such as Journal of Biological Chemistry, Journal of Cell Science and Methods in enzymology on CD-ROM/Methods in enzymology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.